DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

A comparative study between 1 and 2 effective doses of rocuronium for intraoperative neuromonitoring during thyroid surgery.

Author(s): Lu IC, Tsai CJ, Wu CW, Cheng KI, Wang FY, Tseng KY, Chiang FY

Affiliation(s): Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Publication date & source: 2011-04, Surgery., 149(4):543-8. Epub 2011 Jan 14.

Publication type: Comparative Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

BACKGROUND: The goal of this study was to explore an ideal application of rocuronium to enable adequate muscle relaxation for intubation without significantly affecting the evoked potentials measured by intraoperative neuromonitoring during thyroid surgery. METHODS: A total of 80 patients were randomized to receive 1 (group 1, n = 40) or 2 (group 2, n = 40) effective doses (ED(95)) of rocuronium to facilitate electromyographic (EMG) endotracheal tube insertion. Evoked potentials were obtained every 5 minutes by stimulating the vagus nerve between the time period of 30 and 70 minutes after administration of rocuronium. The magnitude of evoked potentials at each time point and the tracheal intubating conditions were compared between groups. Accelerometry (twitch [% TW]) was used to monitor the quantitative degree of neuromuscular transmission at the adductor pollicis muscle. RESULTS: At 30 minutes after administration of rocuronium, the rate of positive EMG response was 100% (40/40) in group 1 and 53% (21/40) in group 2 (P < .001). Positive EMG signals were obtained for all patients in group 2 until 55 minutes after administration of rocuronium. The mean amplitude detected from the time point of 30 to 60 minutes was greater in group 1 than in group 2 (P < .01). The time to tracheal intubation was 208 +/- 59 seconds in group 1 and 114 +/- 26 seconds in group 2 (P < .001). The overall intubating conditions were better in group 2 than in group 1 patients (P < .001). CONCLUSION: A total of 1 ED(95) of rocuronium (0.3 mg/kg) is an optimal dose for intraoperative neuromonitoring during thyroid surgery. Positive and high EMG signals were obtained in all patients at an early stage of operation, and satisfactory intubating conditions were achieved in most patients. Copyright (c) 2011 Mosby, Inc. All rights reserved.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017